Localization of the imidazoline binding domain on monoamine oxidase B

Molecular Pharmacology

Volumn 52, Issue 4, 1997, Pages 549-553

  Raddatz, Rita ^a   Parini, Angelo ^b   Lanier, Stephen M ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b Institut Louis Bugnard   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; CIRAZOLINE; CYANOGEN BROMIDE; DRUG BINDING PROTEIN; GUANIDINE DERIVATIVE; IMIDAZOLINE; LAZABEMIDE; MONOAMINE OXIDASE B INHIBITOR; N (2 AMINOETHYL) 4 CHLOROBENZAMIDE; PARGYLINE; PHENETHYLAMINE;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; DRUG PROTEIN BINDING; HUMAN; HUMAN TISSUE; LIGAND BINDING; LIVER MEMBRANE; MITOCHONDRIAL MEMBRANE; NONHUMAN; PHOTOAFFINITY LABELING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030769472     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.4.549     Document Type: Article

References (23)

1. Tesson, F., I. Limon-Boulez, P. Urban, M. Puype, J, Vandekerckhove, I. Coupry, D. Pompon, and A. Parini. Localization of I2-imidazoline binding sites on monoamine oxidases. J. Biol. Chem. 270:9856-9861 (1995).
2. Raddatz, R., A. Parini, and S. M. Lanier. Imidazoline/guanidinium binding domains on monoamine oxidases: Relationship to subtypes of imidazoline-binding proteins and tissue-specific interaction of imidazoline ligands with monoamine oxidase B. J. Biol. Chem. 270:27961-27968 (1995).
3. Parini, A., C. G. Moudanos, N. Pizzinat, and S. M. Lanier. The elusive family of imidazoline binding sites. Trends Pharmacol. Sci. 17:3-16 (1996).
4. Regunathan, S. and D. J. Reis. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36:511-544 (1966).
5. +1. J. Pharmacol. Exp. Ther. 276:359-364 (1996).
6. Lanier, S. M., B. Ivkovic, I. Singh, J. L. Neumeyer, and V Bakthavachalam. Visualization of multiple imidazoline/guanidinium receptive sites. J. Biol Chem 268:16047-16051 (1993).
7. Ivkovic, B., V. Bakthavachalam, W. Zhang, A. Parini, D. Diz, S. Bosch, J. L. Neumeyer, and S. M. Lanier. Development of a high affinity radioiodinated ligand for identification of imidazoline/guanidinium receptive sites (IGRS): Intratissue distribution in liver, forebrain, and kidney. Mol. Pharmacol. 46:5-23 (1994).
8. Lanier, B., R. Raddatz, V. Bakthavachalam, I. Coupry, J. L. Neumeyer, and S. M. Lanier. Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit. Mol. Pharmacol. 48:703-710 (1995).
9. Schagger, H., and G. von Jagow. Tricine-sodium dodecylsulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1-100 kDa. Analytical Biochem. 166:368-379 (1987).
10. Brunner, H. G., M. Nelen, X. O. Breakefield, H. H. Ropers, and B. A. van Oost. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science (Washington D. C.) 262:578-580 (1993).
11. Tipton, K. F., and T. P. Singer. Advances in our understanding of the mechanisms of neurotoxicity of MPTP and related compounds. J. Neurochem. 61:1191-1206 (1993).
12. Raddatz, R., and S. M. Lanier. Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochem. Intl. 30:109-117 (1997).
13. Bach, A. W. J., N. C. Lan, D. L. Johnson, C. W. Abell, M. E. Bembenek, S.-W. Kwan, P. H. Seeburg, and J. C. Shih. cDNA cloning of human liver monoamine oxidase A and B: Molecular basis of differences in enzymatic properties. Proc. Natl. Acad. Sci. USA 85:4934-4938 (1988).
14. Ito, A., T. Kuwahara, S. Inadome, and Y Sagara. Molecular cloning of a cDNA for rat liver monoamine oxidase B. Biochem. Biophys. Res. Commun. 157:970-976 (1988).
15. Cesura, A. M., J. Gottowik, H.-W. Lahm, G. Lang, R. Imhof, P. Malherbe, U. Röthlisberger, and M. DaPrada. Investigation on the structure of the active site of monoamine oxidase B by affinity labeling with the selective inhibitor lazabemide and by site-directed mutagenesis. Eur. J. Biochem. 236:996-1002 (1996).
16. Carpéné, C., P. Collon, A. Remaury, A. Cordi, A. Hudson, D. Nutt, and M. Lafontan. Inhibition of amine oxidase activity by derivatives that recognize imidazoline 12 sites. J. Pharmacol. Exp. Ther. 272:681-688 (1995).
17. Palaty, V., and E. J. Cragoe, Jr. Inhibition of monoamine oxidase by analogues of amiloride. Mol. Pharmacol. 36:296-301 (1989).
18. 3H]Ro 19-6327: A reversible ligand and affinity labelling probe for monoamine oxidase B. Eur J. Pharmacol. 162:457-465 (1989).
19. Abell, C. W. Monoamine oxidase B from human liver and brain. Methods Enzymol. 142:638-650 (1987).
20. Tsugeno, Y., I. Hirashiki, F. Ogata, and A. Ito. Regions of the molecule responsible for substrate specificity of monoamine oxidase A and B: A chimeric enzyme analysis. J. Biochem. 118:974-980 (1995).
21. Gottowik, J., P. Malherbe, G. Lang, M. DaPrada, and M. Cesura. Structure/function relationships of mitochondrial monoamine oxidase A and B chimeric forms. Eur. J. Biochem. 230:934-942 (1995).
22. Chen, K., H.-F. Wu, and J. C. Shih. Influence of C terminus on monoamine oxidase A and B catalytic activity. J. Neurochem. 66:797-803 (1996).
23. 3H]idazoxan binding sites (12-imidazoline sites) in the human brain: Strong correlation of 12 with monoamine oxidase-B sites. J. Neurochem. 61:881-889 (1993).